Weimao Ding

693 total citations
27 papers, 280 citations indexed

About

Weimao Ding is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Weimao Ding has authored 27 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 21 papers in Hepatology and 2 papers in Surgery. Recurrent topics in Weimao Ding's work include Liver Disease Diagnosis and Treatment (21 papers), Hepatitis B Virus Studies (18 papers) and Hepatitis C virus research (17 papers). Weimao Ding is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Hepatitis B Virus Studies (18 papers) and Hepatitis C virus research (17 papers). Weimao Ding collaborates with scholars based in China, United States and Greece. Weimao Ding's co-authors include Rui Huang, Chao Wu, Xiaomin Yan, Juan Xia, Wenhua Hou, Lili Xu, Gang Yang, Guangming Wang, Yuzhu Liu and Xiaomiao Feng and has published in prestigious journals such as Advanced Functional Materials, Journal of Hazardous Materials and Oncogene.

In The Last Decade

Weimao Ding

22 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weimao Ding China 10 182 171 36 36 27 27 280
Jiang Guo China 12 46 0.3× 56 0.3× 22 0.6× 53 1.5× 24 0.9× 45 323
Aritz Pérez Ruiz de Garibay Germany 13 48 0.3× 40 0.2× 12 0.3× 23 0.6× 10 0.4× 21 489
Nianyue Wang China 10 114 0.6× 129 0.8× 2 0.1× 11 0.3× 49 1.8× 19 335
Shuhui Tao China 12 54 0.3× 26 0.2× 12 0.3× 172 4.8× 14 0.5× 24 470
Giuseppe Russo Italy 7 78 0.4× 49 0.3× 21 0.6× 4 0.1× 174 6.4× 20 356
Minoru Iwasaki Japan 8 129 0.7× 117 0.7× 17 0.5× 3 0.1× 23 0.9× 18 332
Jian Kong China 11 11 0.1× 48 0.3× 7 0.2× 7 0.2× 25 0.9× 27 293
Abigail Zabron United Kingdom 8 46 0.3× 51 0.3× 2 0.1× 11 0.3× 51 1.9× 14 319
Yahui Liu China 10 36 0.2× 53 0.3× 4 0.1× 3 0.1× 67 2.5× 29 435

Countries citing papers authored by Weimao Ding

Since Specialization
Citations

This map shows the geographic impact of Weimao Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weimao Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weimao Ding more than expected).

Fields of papers citing papers by Weimao Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weimao Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weimao Ding. The network helps show where Weimao Ding may publish in the future.

Co-authorship network of co-authors of Weimao Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Weimao Ding. A scholar is included among the top collaborators of Weimao Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weimao Ding. Weimao Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jian, Jie Zhan, Zhiyi Zhang, et al.. (2025). Prevalence and clinical significance of HBeAg-positive chronic hepatitis B patients with and without anti-HBe antibody. Virulence. 16(1). 2534079–2534079.
2.
Ding, Weimao, Bingfeng Chen, Meng Liu, et al.. (2025). Different effects of heterocyclic compounds on the diversity and functions of soil microbiota. Journal of Hazardous Materials. 499. 140318–140318.
4.
Platt, Christopher, Agnieszka Bierżyńska, Weimao Ding, et al.. (2024). Rare heterozygous variants in paediatric steroid resistant nephrotic syndrome – a population-based analysis of their significance. Scientific Reports. 14(1). 18568–18568.
5.
Wang, Jian, Rui Huang, Jiacheng Liu, et al.. (2023). A novel non‐invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of Viral Hepatitis. 30(4). 287–296. 5 indexed citations
6.
Liu, Jiacheng, Jian Wang, Weihua Wu, et al.. (2023). Liver inflammation activity in patients with autoimmune hepatitis with normal alanine aminotransferase and immunoglobulin G levels. Journal of Translational Autoimmunity. 8(6). 100220–100220. 3 indexed citations
7.
Wang, Jian, Jie Zhan, Zhiyi Zhang, et al.. (2023). Clinical characteristics and phase transition of chronic hepatitis B patients with HBeAg and anti-HBe coexistence. Journal of Hepatology. 78. S1094–S1094. 1 indexed citations
8.
Wang, Jian, Yuanwang Qiu, Yuxin Chen, et al.. (2023). NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study. Annals of Hepatology. 29(1). 101155–101155. 6 indexed citations
9.
Liu, Jia‐Cheng, Jian Wang, Xiaomin Yan, et al.. (2021). Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis. Hepatology Communications. 6(4). 855–866. 34 indexed citations
10.
Zhao, Xiang‐An, Jian Wang, Jiacheng Liu, et al.. (2021). Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase. Journal of Clinical and Translational Hepatology. 10(2). 247–253. 7 indexed citations
11.
Wang, Jian, Lijuan Wang, Juan Xia, et al.. (2021). Association of anti‐HBc and liver inflammation in HBeAg‐negative chronic hepatitis B virus‐infected patients with normal ALT and detectable HBV DNA. Journal of Medical Virology. 94(2). 659–666. 11 indexed citations
12.
Wang, Huali, Jian Wang, Juan Xia, et al.. (2020). Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitis. Medicine. 99(34). e21408–e21408. 10 indexed citations
13.
Wang, Jian, Juan Xia, Xiaomin Yan, et al.. (2020). Plateletcrit as a potential index for predicting liver fibrosis in chronic hepatitis B. Journal of Viral Hepatitis. 27(6). 602–609. 11 indexed citations
14.
Wang, Jian, Juan Xia, Xiaomin Yan, et al.. (2020). The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase. Clinics and Research in Hepatology and Gastroenterology. 44(6). 913–922. 11 indexed citations
15.
Wang, Jian, Zhong Chen, Xiaomin Yan, et al.. (2019). The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.. PubMed. 28(153). 149–158. 2 indexed citations
16.
Wang, Jian, Weihua Wu, Xiaomin Yan, et al.. (2019). HBeAg Negativity Is Associated With More Advanced Liver Fibrosis in Patients With Chronic Hepatitis B. Journal of Clinical Gastroenterology. 54(9). 826–831. 3 indexed citations
17.
Wang, Jia, Juan Xia, Xiaomin Yan, et al.. (2018). A novel index using routine clinical parameters for predicting significant liver inflammation in chronic hepatitis B. Journal of Viral Hepatitis. 25(10). 1151–1160. 14 indexed citations
18.
Huang, Rui, Guiyang Wang, Chen Tian, et al.. (2017). Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China. Scientific Reports. 7(1). 8543–8543. 37 indexed citations
19.
Ying, Meidan, Gang Liu, Hiroyuki Shimada, et al.. (2012). Human osteosarcoma CD49f−CD133+ cells: impaired in osteogenic fate while gain of tumorigenicity. Oncogene. 32(36). 4252–4263. 27 indexed citations
20.
Yang, Gang, Wenhua Hou, Xiaomiao Feng, et al.. (2007). Nanocomposites of Polyaniline and a Layered Inorganic Acid Host: Polymerization of Aniline in the Layers, Conformation, and Electrochemical Studies. Advanced Functional Materials. 17(3). 401–412. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026